e to suggest AGN and TEVA in specialty pharma. We can also discuss some names in sectors such as med tech and healthcare distribution. BAML analyst Sumant Kulkarnl reiterated his strong buys on AGN and TEVA overnight. Here are two ways to play the story via convertible preferreds where you get upside participat